Search Within

Benjamin Heath Durham

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (12)
Groups
  1. Center for Hematologic Malignancies (29)
  2. Department of Medicine (29)
  3. GSK Faculty (29)
  4. Hematologic Malignancies, Division of (29)
  5. Human Oncology and Pathogenesis Program (29)
  6. Executive Committee, Center for Hematologic Malignancies (28)

More Groups

People
  1. Omar Abdel-Wahab (18)
  2. Ross Levine (12)
  3. Michael Berger (10)
  4. David Solit (8)
  5. Eli Diamond (8)
  6. Richard Koche (8)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (1)
  4. 2021 (2)
  5. 2020 (2)
  6. 2019 (4)

More Years

Publications
  1. Blood (13)
  2. Nature Medicine (3)
  3. Cancer Discovery (2)
  4. Clinical Cancer Research (2)
  5. Biology of Blood and Marrow Transplantation (1)
  6. Blood Advances (1)

More Publications

Publishers
  1. American Society of Hematology (14)
  2. American Association for Cancer Research (4)
  3. Nature Publishing Group (4)
  4. Cell Press (2)
  5. American Society for Clinical Investigation (1)
  6. Elsevier Inc. (1)

More Publishers

Results (29)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies
    Journal Article

    Krystel-Whittemore, M.; Petrova-Drus, K.; Ptashkin, R. N.; Ewalt, M. D.; Yao, J.; Liu, Y.; Zhu, M.; Benhamida, J.; Durham, B.; Kumar, J.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms
    Journal Article

    Durham, B. H.; Hershkovitz-Rokah, O.; Abdel-Wahab, O.; Yabe, M.; Chung, Y. R.; Itchaki, G.; Ben-Sasson, M.; Asher-Guz, V. A.; Groshar, D.; Doe-Tetteh, S. A.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Overcoming barriers to tumor genomic profiling through direct-to-patient outreach
    Journal Article

    Doe-Tetteh, S. A.; Camp, S. Y.; Reales, D.; Crowdis, J.; Noronha, A. M.; Wolff, B.; Alano, T.; Galle, J.; Selcuklu, S. D.; Viale, A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • RAF-Independent MEK mutations drive histiocytic neoplasms in vivo and are sensitive to single-agent ERK inhibition in patients
    Meeting Abstract

    Durham, B. H.; Singer, M. E.; Benbarche, S.; Erickson, C.; Rahman, J.; Solit, D. B.; Witkowski, M.; Rosen, N.; Abdel-Wahab, O.; Diamond, E. L.
    Blood (2022)

    Fulltext@MSK | Save
  • Therapeutic efficacy of combined JAK1/2, pan-PIM, and CDK4/6 inhibition in myeloproliferative neoplasms
    Journal Article

    Rampal, R. K.; Pinzon-Ortiz, M.; Hanasoge Somasundara, A. V.; Durham, B.; Koche, R.; Spitzer, B.; Mowla, S.; Krishnan, A.; Li, B.; An, W.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Mutant SF3B1 promotes AKT- and NF-κB-driven mammary tumorigenesis
    Journal Article

    Liu, B.; Liu, Z.; Chen, S.; Ki, M.; Erickson, C.; Reis-Filho, J. S.; Durham, B. H.; Chang, Q.; de Stanchina, E.; Sun, Y.; more...
    Journal of Clinical Investigation (2021)

    Fulltext@MSK | Save
  • PRMT5 inhibition modulates E2F1 methylation and gene-regulatory networks leading to therapeutic efficacy in JAK2(V617F)-mutant MPN
    Journal Article

    Pastore, F.; Bhagwat, N.; Pastore, A.; Radzisheuskaya, A.; Karzai, A.; Krishnan, A.; Li, B.; Bowman, R. L.; Xiao, W.; Viny, A. D.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Novel alterations in CSF1R, RET, and other diverse kinases in the histiocytoses with biochemical and structural insights into their mechanisms of activation
    Meeting Abstract

    Durham, B.; Lopez-Rodrigo, E.; Picarsic, J.; Abramson, D.; Rotemberg, V.; De Munck, S.; Pannecoucke, E.; Lu, S.; Pastore, A.; Mandelker, D.; more...
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Stag2 regulates hematopoietic differentiation and self-renewal through alterations in gene expression and topological control
    Meeting Abstract

    Viny, A. D.; Bowman, R. L.; Liu, Y.; Lavallee, V. P.; Eisman, S.; Xiao, W.; Durham, B. H.; Navitski, A.; Park, J.; Braunstein, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • PRMT5 inhibition modulates E2F1 methylation and gene regulatory networks leading to therapeutic efficacy in JAK2VF mutant MPN
    Meeting Abstract

    Pastore, F.; Bhagwat, N.; Krishnan, A.; Pastore, A.; Li, B.; Bowman, R. L.; Xiao, W.; Viny, A. D.; Karzai, A.; Zouak, A.; more...
    Blood (2019)

    Fulltext@MSK | Save